Yang, R.; Han, S.; Clayton, J.; Haghighatian, M.; Tsai, C.-C.; Yao, Y.; Li, P.; Shen, J.; Zhou, Q.
A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function. Cancers 2022, 14, 3763.
https://doi.org/10.3390/cancers14153763
AMA Style
Yang R, Han S, Clayton J, Haghighatian M, Tsai C-C, Yao Y, Li P, Shen J, Zhou Q.
A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function. Cancers. 2022; 14(15):3763.
https://doi.org/10.3390/cancers14153763
Chicago/Turabian Style
Yang, Rongze, Shuyan Han, Joseph Clayton, Mahan Haghighatian, Cheng-Chieh Tsai, Yuan Yao, Pingping Li, Jana Shen, and Qun Zhou.
2022. "A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function" Cancers 14, no. 15: 3763.
https://doi.org/10.3390/cancers14153763
APA Style
Yang, R., Han, S., Clayton, J., Haghighatian, M., Tsai, C.-C., Yao, Y., Li, P., Shen, J., & Zhou, Q.
(2022). A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function. Cancers, 14(15), 3763.
https://doi.org/10.3390/cancers14153763